Drug pricing

News

MFN affecting Swiss medicines access, says Interpharma

Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.

Market Access

Three separate injections - blue, red, and yellow - take off against black background

Why global pharmaceutical reforms are quietly redirecting ra...

Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs

News

Colorado's pathfinder medicine price-cap move stalls

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on blockbuster immunology drug Enbrel.

News

EFPIA report adds to pressures on EU drug pricing policy

Pharma trade body EFPIA says access to new medicines is worsening across Europe, as it makes the socioeconomic case for spending more on novel drugs.

News

US launches probe of German 'underpayment' for medicines

A Section 301 probe by the US Trade Representative into Germany's medicine pricing and reimbursement policies raises the threat of punitive tariffs.

News

Germany said to be backtracking on pharma rebate changes

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

MFN affecting Swiss medicines access, says Interpharma

Why global pharmaceutical reforms are quietly redirecting ra...

Colorado's pathfinder medicine price-cap move stalls

EFPIA report adds to pressures on EU drug pricing policy

US launches probe of German 'underpayment' for medicines

Germany said to be backtracking on pharma rebate changes

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Drug pricing

Editor's Picks